SCHEMBL7978871

SCHEMBL7978871

CCOC(=O)Cc1nc2c(O)cccc2n1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CHEK1 O14757 1/20 0.41
TLR8 Q9NR97 1/20 0.40
ALDH1A1 P00352 5/20 0.40
KDM4E B2RXH2 4/20 0.40
HSD17B10 Q99714 4/20 0.40
HPGD P15428 2/20 0.40
TSHR P16473 1/20 0.40
SAE1 Q9UBE0 1/20 0.40
UBA2 Q9UBT2 1/20 0.40
BDKRB2 P30411 1/20 0.40
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3426153 0.84 NR1H2 (0.42) AKT1SMN1; SMN2L3MBTL1CHEK1ALDH1A1
SCHEMBL7018296 0.80 RAB9A (0.58) SMN1; SMN2ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL7981661 0.79 BDKRB2 (0.48) SMN1; SMN2L3MBTL1ALDH1A1KDM4EBDKRB2
SCHEMBL7975692 0.78 TLR8 (0.49) SMN1; SMN2TLR8ALDH1A1KDM4EHPGD
SCHEMBL7975769 0.78 ALDH1A1 (0.51) TLR8ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL7965261 0.75 TLR8 (0.43) SMN1; SMN2L3MBTL1TLR8KDM4ETSHR
SCHEMBL7977149 0.72 TLR8 (0.46) CA12CA1CA2CA7CA9
SCHEMBL7479778 0.70 TSHR (0.46) L3MBTL1ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL3194071 0.70 CYP1A2 (0.49) SMN1; SMN2TLR8ALDH1A1KDM4EHPGD
SCHEMBL6952373 0.69 BRD4 (0.42) SMN1; SMN2ALDH1A1KDM4EHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194396-B1 ANTIALLERGENS; ANTIINFLAMMATION AGENTS; AUTOIMMUNE DISEASE; ANTISHOCK AGENTS; ANALGESICS; E.G., A 4 OR 7-PHENYLALKYLENE-OXYBENZIMIDAZOLE UNSUBSTITUTED OR SUBSTITUTED IN THE 1,2,3-POSITION WITH AN OXY, AMINO AND/OR THIO GROUP FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-02-27 US disclosed
US-6083961-A FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES SUCH AS ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-04 US disclosed
EP-0774462-A1 HETEROCYCLIC COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-05-21 EP disclosed